Are you looking to contribute to medical innovation that is making an impact on the lives of PTSD patients?
Evren Technologies is looking for investors to help fund the final stages of FDA clinical trials and go-to-market activities for the Phoenix CR system.
Interested investors are encouraged to contact us for more information on how to support our efforts.
Together, we can empower patients to rise above PTSD and improve their lives.
What is VNS?
The vagus is the key component of the parasympathetic branch of the autonomic nervous system, and because the sympathetic and parasympathetic nervous systems act reciprocally -- when one goes up, the other goes down -- the vagus nerve is critical in many therapeutic areas due to its beneficial effect in restoring balance in cases where sympathetic activity is abnormally raised or parasympathetic activity is lowered.
Researchers are investigating: VNS mechanisms of action, restoration of autonomic balance, laying new neural pathways during tasks, reduction of symptoms and systemic imflammatory responses and much more...
$232 Billion Market Opportunity
Why Invest with us?
Our disruptive bioelectronic therapeutic technology, along with a multi-billion-dollar market opportunity and unmet medical need, is prime for investment opportunities.
The unmet medical need, clinical validation, patient appeal and product market fit create a favorable position in the rapidly growing bioelectronic, AI and wearable industry segments.
Our demonstrated capacity to raise extramural funds from the NIH and Defense Department, coupled with our potential to capitalize and capture additional funding, make us an attractive investment.
The potential to capture and organize health care clinical outcomes and usage data represents both short- and long-term data collation and treatment algorithm opportunities.
Our experienced management, strong IP position and label expansion opportunities resonates with investors.
Learn more about our FDA Breakthrough Device Designation award.
Why does Ptsd matter?
PTSD is a devastating psychiatric disorder caused by exposure to a horrific or life-threatening trauma. People with PTSD have difficulty sleeping, nightmares, persistent frightening flashbacks, sudden pathologically-intense outbursts of anger, violence, or anxiety, feel numb or detached, and avoid “triggers” (people or places that remind them of the trauma).
The clinical, social, and financial burdens are enormous. The annual cost to society is estimated at over $232 billion. In the VA alone more than 900,000 veterans receive PTSD disability compensation.
What are the Unmet medical Needs?
There is no cure, and current treatment options are inadequate. Over 12 million Americans have PTSD; 4.2 million of them (35%) never seek help and of the remainder who do seek treatment, few are satisfied with the result. Among those treated, approximately 2/3 (66%) retained their PTSD diagnosis after treatment. Only 9% feel fully recovered. Thus, there is an unmet need affecting about 9 4 million Americans with PTSD.
taVNS Research Device
The Phoenix® CR is designed specifically to produce high-quality transcutaneous auricular vagus nerve stimulation (taVNS) data from human clinical trials
This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure or prevent any disease or medical condition. This device is not available for commercial sale in the United States. It is an investigational device limited by law to use under IRB protocol.
Soft, Conforming Earpiece
Made of soft silicone.
Available in 3 sizes:
Small, Medium and Large
Track usage & adherence
Long battery life
Evren taVNS Research Areas
Traumatic Brain Injury
Cognition and Learning
“It’s not a drug that I’m putting in my system and its not something that I’m smoking. So, if you’re telling me that you can put something in my ear and make me better, sign me up every day of the week!”
- Andy, from Evren's PTSD Pilot Study